Literature DB >> 11958888

Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results.

Mohamed A Elshaikh1, Ashraf S Mahmoud-Ahmed, Sam E Kinney, Benjamin G Wood, Joung H Lee, Gene H Barnett, John H Suh.   

Abstract

PURPOSE: To compare the outcome of salvage radiotherapy (RT) and surgery for recurrent head-and-neck chemodectomas.
MATERIALS AND METHODS: We retrospectively studied 70 patients with benign chemodectomas of the head and neck treated with surgery at the Cleveland Clinic between July 1969 and August 1999; 29 of these patients were diagnosed with recurrent tumors. Salvage RT was used in 12 patients (gamma knife radiosurgery for 7, conventional external beam RT for 4, and intensity-modulated RT for 1 patient). The median follow-up was 55 months for the entire group of 70 patients.
RESULTS: The median time to recurrence was 36 months. Of the recurrences, 16 were glomus jugulare, 7 were carotid body tumors, 5 were glomus tympanicum, and 1 was thyroid paraganglioma. RT was used in 12 patients (9 patients with glomus jugulare, 2 with glomus tympanicum, and 1 with thyroid paraganglioma). Surgery was performed in 17 patients (7 patients with glomus jugulare, 7 with carotid body, and 3 with glomus tympanicum). For patients with glomus jugulare and glomus tympanicum tumors, the 5-year freedom from disease progression was 100% for patients treated with RT vs. 62% for those treated with surgery (p = 0.0124). Seven patients with carotid body tumors and 1 patient with thyroid paraganglioma were treated successfully with surgery and RT, respectively. No significant side effects were associated with RT; however, postoperative complications occurred in 8 of the 17 surgery patients (new cranial nerve palsies, meningitis, infection, and cerebrospinal fluid leak).
CONCLUSION: Salvage RT appears superior to surgery and should be considered the treatment of choice for patients with recurrent glomus jugulare and glomus tympanicum tumors. For recurrent carotid body tumors, surgery produced excellent local control, most likely because of the easier resectability in this location.

Entities:  

Mesh:

Year:  2002        PMID: 11958888     DOI: 10.1016/s0360-3016(01)02751-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases.

Authors:  Patrice Tran Ba Huy; Romain Kania; Michèle Duet; Bernadette Dessard-Diana; Jean-Jacques Mazeron; Rania Benhamed
Journal:  Skull Base       Date:  2009-01

2.  [Endocrine surgery for neck paraganglioma: operation, radiation therapy or wait and scan?].

Authors:  R Schneider; J Ukkat; P Nguyen-Thanh; K Lorenz; S Plontke; C Behrmann; C Sekulla; H Dralle
Journal:  Chirurg       Date:  2012-12       Impact factor: 0.955

3.  First-bite syndrome in oncologic patients.

Authors:  Tiago Porfírio Costa; Carlos Eugenio Nabuco de Araujo; Joana Filipe; António Marques Pereira
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-26       Impact factor: 2.503

Review 4.  Radiosurgery of glomus jugulare tumors: a meta-analysis.

Authors:  Zachary D Guss; Sachin Batra; Charles J Limb; Gordon Li; Michael E Sughrue; Kristin Redmond; Daniele Rigamonti; Andrew T Parsa; Steven Chang; Lawrence Kleinberg; Michael Lim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

5.  Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.

Authors:  Céline Heimburger; Francis Veillon; David Taïeb; Bernard Goichot; Sophie Riehm; Julie Petit-Thomas; Gerlinde Averous; Marcela Cavalcanti; Fabrice Hubelé; Gerard Chabrier; Izzie Jacques Namer; Anne Charpiot; Alessio Imperiale
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-03       Impact factor: 9.236

6.  Does Catecholamine Secretion from Head and Neck Paragangliomas Respond to Radiotherapy? Case Report and Literature Review.

Authors:  Francis T Hall; Bayardo Perez-Ordonez; Robert G Mackenzie; Ralph W Gilbert
Journal:  Skull Base       Date:  2003-11

7.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.

Authors:  Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-19       Impact factor: 2.503

8.  External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.

Authors:  L Fishbein; L Bonner; D A Torigian; K L Nathanson; D L Cohen; D Pryma; K A Cengel
Journal:  Horm Metab Res       Date:  2012-05-07       Impact factor: 2.936

9.  Head and neck paragangliomas: 30-year experience.

Authors:  Cristina Valero; Ian Ganly; Jatin P Shah
Journal:  Head Neck       Date:  2020-05-19       Impact factor: 3.147

10.  Head and neck paragangliomas: Ten years of experience in a third health center. A cohort study.

Authors:  Boutaina Merzouqi; Khadija El Bouhmadi; Youssef Oukesou; Sami Rouadi; Redallah Larbi Abada; Mohamed Roubal; Mohamed Mahtar
Journal:  Ann Med Surg (Lond)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.